DILI Associated with Skin Reactions-Reference-Cited by-同舟云学术

DILI Associated with Skin Reactions

Published:2018-07-12 Issue:3 Volume:17 Page:225-234
ISSN:2195-9595
Container-title:Current Hepatology Reports
language:en
Short-container-title:Curr Hepatology Rep

Author:

Rahnama-Moghadam Sahand,Tillmann Hans L.

Publisher

Springer Science and Business Media LLC

Subject

Virology,Hepatology

Link

http://link.springer.com/article/10.1007/s11901-018-0414-x/fulltext.html

Reference55 articles.

1. NEXAVAR (sorafenib) [package insert] Bayer HealthCare Pharmaceuticals Inc. 2010.

2. INCIVEK (telaprevir) [package insert] Vertex Pharmaceuticals Incorporated. 2011.

3. Carlson MK, Gleason PP, Sen S. Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity. Pharmacotherapy. 2001;21(1):108–13.

4. Fung M, Thornton A, Mybeck K, Wu HJ, Hornbuckle K, Muniz E. Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical Markets-1960 to 1999. Therapeutic Innov Regul Sci. 2001;35:293–317.

5. • Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990;11(2):272. Paper set the stage for defining criteria who to assess drug induced liver injury.–6.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions;Journal of Clinical Medicine;2021-11-15

2. Signatures in drug-induced liver injury;Current Opinion in Gastroenterology;2020-05

3. Hepatotoxicity; Drug-Induced Liver Injury;Encyclopedia of Gastroenterology;2020

4. Tools for causality assessment in drug-induced liver disease;Current Opinion in Gastroenterology;2019-05